BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 23632128)

  • 1. Safety and efficacy of intravenous infusion of allogeneic cryopreserved mesenchymal stem cells for treatment of chronic kidney disease in cats: results of three sequential pilot studies.
    Quimby JM; Webb TL; Habenicht LM; Dow SW
    Stem Cell Res Ther; 2013 Apr; 4(2):48. PubMed ID: 23632128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transplantation of amniotic membrane-derived multipotent cells ameliorates and delays the progression of chronic kidney disease in cats.
    Vidane AS; Pinheiro AO; Casals JB; Passarelli D; Hage M; Bueno RS; Martins DS; Ambrósio CE
    Reprod Domest Anim; 2017 Apr; 52 Suppl 2():316-326. PubMed ID: 27774657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of intravenous adipose-derived allogeneic mesenchymal stem cells for the treatment of feline chronic kidney disease: a randomized, placebo-controlled clinical trial in eight cats.
    Quimby JM; Webb TL; Randall E; Marolf A; Valdes-Martinez A; Dow SW
    J Feline Med Surg; 2016 Feb; 18(2):165-71. PubMed ID: 25784460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of exposure to microbial ligands, immunosuppressive drugs and chronic kidney disease on endogenous immunomodulatory gene expression in feline adipose-derived mesenchymal stem cells.
    Creamer DG; Schmiedt CW; Bullington AC; Caster CM; Schmiedt JM; Hurley DJ; Berghaus RD
    J Feline Med Surg; 2022 Jun; 24(6):e43-e56. PubMed ID: 35302413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of allogeneic feline uterine-derived mesenchymal stromal cell intravenous treatment on renal function of nephrectomized cats with chronic kidney disease.
    Zacharias S; Welty MB; Sand TT; Black LL
    Res Vet Sci; 2021 Dec; 141():33-41. PubMed ID: 34653723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intra-arterial renal infusion of autologous mesenchymal stem cells for treatment of chronic kidney disease in cats: Phase I clinical trial.
    Thomson AL; Berent AC; Weisse C; Langston CE
    J Vet Intern Med; 2019 May; 33(3):1353-1361. PubMed ID: 30924554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of intrarenal mesenchymal stem cell injection for treatment of chronic kidney disease in cats: a pilot study.
    Quimby JM; Webb TL; Gibbons DS; Dow SW
    J Feline Med Surg; 2011 Jun; 13(6):418-26. PubMed ID: 21334237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of acute respiratory distress syndrome with allogeneic adipose-derived mesenchymal stem cells: a randomized, placebo-controlled pilot study.
    Zheng G; Huang L; Tong H; Shu Q; Hu Y; Ge M; Deng K; Zhang L; Zou B; Cheng B; Xu J
    Respir Res; 2014 Apr; 15(1):39. PubMed ID: 24708472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of allogeneic mesenchymal stem cell administration in a model of acute ischemic kidney injury in cats.
    Rosselli DD; Mumaw JL; Dickerson V; Brown CA; Brown SA; Schmiedt CW
    Res Vet Sci; 2016 Oct; 108():18-24. PubMed ID: 27663365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reparative therapy for acute ischemic stroke with allogeneic mesenchymal stem cells from adipose tissue: a safety assessment: a phase II randomized, double-blind, placebo-controlled, single-center, pilot clinical trial.
    Díez-Tejedor E; Gutiérrez-Fernández M; Martínez-Sánchez P; Rodríguez-Frutos B; Ruiz-Ares G; Lara ML; Gimeno BF
    J Stroke Cerebrovasc Dis; 2014; 23(10):2694-2700. PubMed ID: 25304723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amelioration of diabetic retinopathy by engrafted human adipose-derived mesenchymal stem cells in streptozotocin diabetic rats.
    Yang Z; Li K; Yan X; Dong F; Zhao C
    Graefes Arch Clin Exp Ophthalmol; 2010 Oct; 248(10):1415-22. PubMed ID: 20437245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone marrow-mesenchymal stromal cell infusion in patients with chronic kidney disease: A safety study with 18 months of follow-up.
    Makhlough A; Shekarchian S; Moghadasali R; Einollahi B; Dastgheib M; Janbabaee G; Hosseini SE; Falah N; Abbasi F; Baharvand H; Aghdami N
    Cytotherapy; 2018 May; 20(5):660-669. PubMed ID: 29580865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced renoprotective effect of GDNF-modified adipose-derived mesenchymal stem cells on renal interstitial fibrosis.
    Li S; Wang Y; Wang Z; Chen L; Zuo B; Liu C; Sun D
    Stem Cell Res Ther; 2021 Jan; 12(1):27. PubMed ID: 33413640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of proliferative and immunomodulatory potential of adipose-derived mesenchymal stem cells from young and geriatric cats.
    Zajic LB; Webb TL; Webb P; Coy JW; Dow SW; Quimby JM
    J Feline Med Surg; 2017 Oct; 19(10):1096-1102. PubMed ID: 27913779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adipose-derived mesenchymal stem cells protects renal function in a rat model of emphysema.
    Hoseinynejad K; Radan M; Dianat M; Nejaddehbashi F
    Tissue Cell; 2021 Dec; 73():101613. PubMed ID: 34364156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allogeneic mesenchymal stem cells as induction therapy are safe and feasible in renal allografts: pilot results of a multicenter randomized controlled trial.
    Sun Q; Huang Z; Han F; Zhao M; Cao R; Zhao D; Hong L; Na N; Li H; Miao B; Hu J; Meng F; Peng Y; Sun Q
    J Transl Med; 2018 Mar; 16(1):52. PubMed ID: 29514693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GDNF enhances the anti-inflammatory effect of human adipose-derived mesenchymal stem cell-based therapy in renal interstitial fibrosis.
    Wang Z; Li S; Wang Y; Zhang X; Chen L; Sun D
    Stem Cell Res; 2019 Dec; 41():101605. PubMed ID: 31706095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous adipose-derived mesenchymal stem cell therapy for the treatment of feline asthma: a pilot study.
    Trzil JE; Masseau I; Webb TL; Chang CH; Dodam JR; Liu H; Quimby JM; Dow SW; Reinero CR
    J Feline Med Surg; 2016 Dec; 18(12):981-990. PubMed ID: 26384398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-122 modification enhances the therapeutic efficacy of adipose tissue-derived mesenchymal stem cells against liver fibrosis.
    Lou G; Yang Y; Liu F; Ye B; Chen Z; Zheng M; Liu Y
    J Cell Mol Med; 2017 Nov; 21(11):2963-2973. PubMed ID: 28544786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization and Multilineage Differentiation of Domestic and Black-Footed Cat Mesenchymal Stromal/Stem Cells from Abdominal and Subcutaneous Adipose Tissue.
    Gómez MC; Qin Q; Biancardi MN; Galiguis J; Dumas C; MacLean RA; Wang G; Pope CE
    Cell Reprogram; 2015 Oct; 17(5):376-92. PubMed ID: 26317245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.